Does Lactobacillus Rhamnosus GG Lower Inflammation? Evidence Review
This conversation explores whether Lactobacillus rhamnosus GG (LGG) effectively reduces inflammation. Based on two studies from Pillser's research database, evidence leans beneficial, showing LGG modulates cytokines like IL-10 and TNF-α. However, the small study count suggests the evidence base is still developing.
Does taking Lactobacillus rhamnosus GG actually help lower inflammation levels, or is the evidence pretty neutral on that?
Great question. Based on the data from Pillser's research database, the evidence leans beneficial rather than neutral.
What the Research Shows
Pillser has cataloged 2 studies on Lactobacillus rhamnosus GG (LGG) and inflammation, and both reported beneficial effects1:
-
A 2026 narrative review found that LGG can "attenuate inflammation through cytokine modulation" — specifically increasing the anti-inflammatory cytokine IL-10, while decreasing pro-inflammatory cytokines TNF-α and IL-6. The effect was described as small but statistically significant2.
-
A 2025 observational study in the context of diabetic kidney disease found that pro-inflammatory cytokine levels (IL-6, TNF-α) decreased significantly, while anti-inflammatory mediators (IL-10, TGF-β) showed enhanced expression — a moderate, statistically significant effect3.
Summary of Evidence
Outcome Beneficial Neutral Harmful Reduced Inflammation 2 studies 0 0 Key Takeaway
The available evidence suggests that Lactobacillus rhamnosus GG does appear to help lower inflammation, primarily through modulating cytokine balance — tipping the scales toward anti-inflammatory signals (like IL-10) and away from pro-inflammatory ones (like TNF-α and IL-6). That said, the total study count is small (2 studies), and one of them is a review paper, so the evidence base is still developing. Larger, more robust clinical trials would help solidify these conclusions.
Footnotes
-
Pillser research database, Lactobacillus rhamnosus GG and Reduced Inflammation. ↩
-
"Molecular Pathways and Clinical Applications of Probiotics as Effective Supporters of Intestinal, Neurologic, and Cardiovascular Health: a Narrative Review," Pillser, 2026. ↩
-
"Gut Microbiome Engineering for Diabetic Kidney Disease Prevention: A Lactobacillus rhamnosus GG Intervention Study," Pillser, 2025. ↩
-